Anavex Life Sciences Corp. (AVXL)
2.985
-0.14
(-4.63%)
USD |
NASDAQ |
Aug 28, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences 30-Day Average Daily Volume : 961089.8 for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 961089.8 |
| August 26, 2026 | 964789.5 |
| August 25, 2026 | 949837.1 |
| August 24, 2026 | 896838.6 |
| August 21, 2026 | 925561.0 |
| August 20, 2026 | 934524.5 |
| August 19, 2026 | 945810.4 |
| August 18, 2026 | 949851.2 |
| August 17, 2026 | 964879.2 |
| August 14, 2026 | 970619.0 |
| August 13, 2026 | 986517.2 |
| August 12, 2026 | 996465.3 |
| August 11, 2026 | 1.004M |
| August 10, 2026 | 1.008M |
| August 07, 2026 | 1.126M |
| August 06, 2026 | 1.123M |
| August 05, 2026 | 1.119M |
| August 04, 2026 | 1.107M |
| August 03, 2026 | 1.079M |
| July 31, 2026 | 1.328M |
| July 30, 2026 | 1.337M |
| July 29, 2026 | 1.328M |
| July 28, 2026 | 1.322M |
| July 27, 2026 | 1.337M |
| July 24, 2026 | 1.345M |
| Date | Value |
|---|---|
| July 23, 2026 | 1.342M |
| July 22, 2026 | 1.332M |
| July 21, 2026 | 1.340M |
| July 20, 2026 | 1.344M |
| July 17, 2026 | 1.347M |
| July 16, 2026 | 1.318M |
| July 15, 2026 | 1.373M |
| July 14, 2026 | 1.402M |
| July 13, 2026 | 1.416M |
| July 10, 2026 | 1.419M |
| July 09, 2026 | 1.433M |
| July 08, 2026 | 1.434M |
| July 07, 2026 | 1.445M |
| July 06, 2026 | 1.449M |
| July 02, 2026 | 1.457M |
| July 01, 2026 | 1.470M |
| June 30, 2026 | 1.464M |
| June 29, 2026 | 1.474M |
| June 26, 2026 | 1.490M |
| June 25, 2026 | 1.391M |
| June 24, 2026 | 1.401M |
| June 23, 2026 | 1.411M |
| June 22, 2026 | 1.410M |
| June 18, 2026 | 1.415M |
| June 17, 2026 | 1.154M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.636M |
| Oncolytics Biotech, Inc. | 855481.3 |
| Sangamo Therapeutics, Inc. | 3.456M |
| Sarepta Therapeutics, Inc. | 3.053M |
| Anixa Biosciences, Inc. | 254432.5 |